Drug
Rmenb Omv NZ Vaccine
Rmenb Omv NZ Vaccine: highest development phase Phase 3, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| rMenB+OMV NZ vaccine NCT06995430 | Phase 3 | Meningitis |
Latest
No recent events.
Follow Rmenb Omv NZ Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.